Now I have enough calibration data. Let me write the final consolidated review.

## Summary
CMT introduces a variational framework that constructs intermediate distributions between a tractable prior and an unnormalized target by jointly constraining KL divergence and entropy decay at each step. The resulting geometric-tempered annealing path admits closed-form analytical expressions (Propositions 2.1–2.3), and the method is instantiated with normalizing flows. Evaluated on four molecular Boltzmann generator benchmarks up to d=219, CMT achieves the best EUBO and ESS across all systems while using comparable or fewer target evaluations than strong baselines (FAB, TA-BG).

## Strengths
- **Closed-form analytical solutions for constrained transport problems.** Propositions 2.1, 2.2, and 2.3 (Equations 5, 8, 10) derive explicit forms for the optimal intermediate densities under trust-region, entropy, and combined constraints. The combined geometric-tempered path (Eq. 10) is a new construction that does not arise from standard geometric schedules. This is a genuine theoretical contribution that goes beyond prior work relying on predefined paths or black-box optimization.
- **Consistent and substantial improvements across all four molecular systems.** Table 1 shows CMT achieves the best EUBO and ESS across systems of increasing complexity. On the two largest systems—alanine hexapeptide (d=180) and the new ELIL tetrapeptide (d=219)—CMT attains 29.63% and 26.06% ESS respectively, versus the next-best TA-BG at 18.22% and 13.75% (1.6–1.9× improvement), using the same number of target evaluations.
- **Ablation study cleanly demonstrates that both constraints are necessary.** Figures 2–3 compare four variants on alanine hexapeptide. Only the combined geometric-tempered variant avoids visible mode collapse (Figure 3), and only the combined variant maintains high ESS between successive intermediates throughout training (Figure 2b). This is the clearest available ablation evidence in the Boltzmann generator literature.
- **Introduces the ELIL tetrapeptide benchmark (d=219),** the largest molecular system studied in the pure-energy-evaluation setting, with ground-truth MD data released publicly (via Zenodo DOI).
- **Entropy *decay* constraint** (H(q_i) − H(q) ≤ ε_ent, as opposed to constraining absolute entropy) is a well-motivated adaptation for sampling problems where the target entropy is unknown, and the paper provides the first explicit connection between such constrained optimization and annealing paths.

## Weaknesses

### Fatal
None.

### Major
- **Equation (16) contains a mathematical discrepancy that must be resolved.** The paper's Eq. (10) defines Z_{i+1}(λ,η) = ∫ q_i^{1/(1+λ+η)} p̃^{1/(1+λ+η)} dx. Written as an expectation under q_i, this becomes E_{x∼q_i}[ q_i(x)^{-(λ+η)/(1+λ+η)} · p̃(x)^{1/(1+λ+η)} ]. However, Eq. (16) gives E_{x∼q_i}[ (p̃(x)/q_i(x)^{1+η})^{1/(1+λ+η)} ], which expands to p̃^{1/(1+λ+η)} · q_i^{-(1+η)/(1+λ+η)}. The exponent on q_i differs: the correct expression has −(λ+η) in the numerator while the paper has −(1+η). The two agree only when λ=1. If the implementation follows Eq. (16), the dual optimization solves for multipliers that minimize a different objective than claimed, and the resulting intermediate densities would not satisfy the intended constraints. The authors must clarify whether their code uses the correct expression and correct the equation accordingly. This is not a minor typo—the paper as written is internally inconsistent, and the reader cannot determine the correct algorithm without author clarification.

### Minor
- **The "2.5× higher ESS" claim in the abstract and conclusion is overstated.** The actual ratios against the *best* baseline on each system are: 1.02× (alanine dipeptide), 1.04× (tetrapeptide), 1.63× (hexapeptide), 1.90× (ELIL tetrapeptide). The 2.5× figure only arises when comparing CMT to FAB (not the best baseline) on ELIL tetrapeptide (3.6×) or cherry-picking across systems. The claim should be qualified (e.g., "up to 2.5× compared to FAB on the largest system").
- **RAM TV on ELIL tetrapeptide contradicts "consistently surpasses" / "outperforms across all systems and metrics" narrative.** TA-BG achieves RAM TV of 2.54×10⁻² while CMT achieves 3.13×10⁻², meaning TA-BG produces Ramachandran plots closer to ground truth on the most challenging system. The abstract claims CMT "consistently surpasses state-of-the-art" and Section 5.2 says it "outperforms the baselines across all systems and metrics" (line 237)—both are false for this metric-method combination. Acknowledging this trade-off would improve the paper's credibility.
- **The entropy-constrained path (Eq. 7) alone does not interpolate from q_0 to p.** Proposition 2.2 yields q_{i+1} ∝ p̃^{1/(1+η)}, which depends only on p. Theorem 2.4 confirms q_i ∝ p̃^{α_i} for i≥1. The paper acknowledges related concerns (lines 94–96) but still characterizes the tempered path as an "annealing path that interpolates between q_0 and p" (line 116), which is misleading for the entropy-only case. Since the actual method uses the combined path, this does not affect the core contribution but the framing should be corrected.

### Trivial
- Algorithm 1 (line 168) labels the dual function as g_{\text{w-ent}}^{(i+1)} while Eq. (11) defines it as g_{\text{tr-ent}}^{(i+1)} — the subscript is inconsistent.

## Nice-to-Haves
- Sensitivity analysis for the constraint bounds ε_tr and ε_ent would help assess whether results are robust or depend on careful tuning.
- Reporting the number of annealing steps T̃ explicitly (mentioned as fixed but value not stated in main text).
- Wall-clock or gradient-update comparison would contextualize the efficiency trade-off acknowledged in the Conclusion.
- Code release would aid reproducibility, especially given the ambiguity around Eq. (16).

## Removed Points
These points were flagged by reviewers but removed for the reasons stated below:
- **Criticism questioning existence/release status of models, benchmarks, or datasets:** The reviewer noted "no code is mentioned" and raised reproducibility concerns based on this. Since the paper releases MD data via Zenodo and code is not required for review, this is not a valid weakness per the venue's policies. Code availability is a nice-to-have, not a weakness.
- **"The trust-region path still suffers from mass teleportation" framing in weakness #2:** The paper itself acknowledges this in Figure 1 and the text; the reviewer's claim that the tempered path "does not interpolate" is partially correct but the paper already discusses the limitations. Reduced to Minor tier.
- **Criticism about undisclosed hyperparameters and implementation details:** The reviewer mentioned "the number of annealing steps T̃ is not reported in the main text." This belongs in nice-to-have suggestions, not weaknesses.
- **Claim that assertions about variance control (line 144) and 0.01% cost "cannot be evaluated" because appendix is not provided:** The paper states these claims and refers to the appendix for details. Missing appendix content in the extraction is a parser artifact, not a paper flaw.
- **Speculative fatal interpretation of Eq. (16):** The harsh critic called this "structural" and suggested the algorithm's correctness is in question. While the mathematical discrepancy is real and must be fixed, there is no evidence the implementation follows the wrong expression. Demoted from "structural/fatal" to Major.
- **Several superficial strengths from Strength Finder** were removed: "Computational overhead of Lagrangian dual optimization is negligible" (based on a single datapoint), generic praise about addressing important problems, and statements that lacked concrete evidence.
- **"Missing related works"** — not included per the rules since external sources cannot confirm their existence.

## Novel Insights
None beyond the paper's own contributions. The observation that combining a trust-region (KL) constraint with an entropy-decay constraint yields a geometric-tempered path with an analytical form (Proposition 2.3) is itself the paper's core novelty.

## Suggestions
- **Fix Eq. (16):** Correct the exponent on q_i from −(1+η) to −(λ+η) in the numerator, or provide the correct derivation if the paper's current expression is intentional (though I believe it is a typo).
- **Qualify the "2.5×" and "consistently surpasses" claims:** Replace "over 2.5× higher" with a precise statement (e.g., "up to 3.6× higher ESS than FAB on the largest system") and replace "outperforms baselines across all systems and metrics" with a more nuanced statement that acknowledges the RAM TV result on ELIL tetrapeptide.
- **Add the number of annealing steps T̃ to the main experimental setup.**
- **Consider a sensitivity analysis for ε_tr and ε_ent** on at least one system.

### Calibration Anchors
All anchors from the deepreview_13k_calibration corpus:

| Anchor | Path | Avg Score | Round | Comparison |
|--------|------|-----------|-------|------------|
| DynamicsDiffusion | kKXIYUi8ff.md | 3.00 | 1 | Much weaker—no theoretical contribution, small experiments |
| Flow-based imputation | rcmhydaEJp.md | 3.00 | 1 | Different problem, weaker execution |
| Achieving Dynamic Accuracy | ItPYVON0mI.md | 3.00 | 1 | Different problem (CG potentials), weaker |
| Phase-aware Training | SEvJfuCtPY.md | 3.00 | 1 | Different problem, limited scope |
| Annealing Flow | XcAJ0qsMgh.md | 3.60 | 1 | Similar approach but much weaker theory+experiments; our paper is clearly stronger |
| **Fisher-Rao Curves (Sampling Boltzmann)** | TUvg5uwdeG.md | **6.40** | 1,2,3 | Most similar anchor. Strong theory but experiments only 2D/8D; our paper has stronger empirical validation but has Eq(16) error |
| BoPITO | pRCOZllZdT.md | 7.00 | 1,2 | Strong anchor, experiments limited to 1D+alanine dipeptide; accepted. Our paper has broader experiments |
| Provable Benefit of Annealed LMC | P6IVIoGRRg.md | 7.00 | 1 | Theory paper, different setting |
| BNEM | ybWOYIuFl6.md | 6.00 | 1,2,3 | Boltzmann sampler, experiments on tiny systems (GMM 40, DW-4); rejected. Our paper has more convincing experiments |
| Generator Matching | RuP17cJtZo.md | 8.00 | 1 | Strong generative theory, different problem |
| Improved SVGD Rates | sbG8qhMjkZ.md | 8.00 | 1 | Theory paper, different topic |
| SMC for LLMs | xoXn62FzD0.md | 8.00 | 1 | Unrelated topic |
| T-IB for Markov Processes | bH6T0Jjw5y.md | 8.00 | 1 | Unrelated topic |
| FreeFlow (free energy) | D2EdWRWEQo.md | 5.50 | 2 | Related (flow+MD) but different task; rejected |
| MetaGFN | fBJo3wwZeJ.md | 4.60 | 2 | Different method (GFlowNets) |
| Molecular conformer generation | Jj4XIKX4TJ.md | 6.00 | 2 | Different task (conformer generation with MD data) |
| Underdamped Diffusion Bridges | Q1QTxFm0Is.md | 6.80 | 2 | Strong sampling framework, good experiments; accepted |
| Variational Search Distributions | 1vrpdV9U3i.md | 6.50 | 2 | Different problem (discrete design) |
| Bayesian Experimental Design | h8yg0hT96f.md | 7.33 | 2 | Different problem |
| NETS: Non-Equilibrium Transport | 8NiTKmEzJV.md | 6.25 | 3 | Similar task (annealed sampling), good theory; rejected. Comparable quality |

**Round 1 bracket**: [4.5, 7.0]. The paper is clearly above the 3.0 weak anchors and below the 8.0 theoretical papers on different topics.

**Round 2 narrowing**: Compared against Fisher-Rao Curves (6.40), BNEM (6.00), NETS (6.25), Underdamped Diffusion Bridges (6.80), and BoPITO (7.00). The paper's experimental scope is substantially broader than all of these (systems up to d=219 vs 2D toys or single small systems), and its theoretical contribution (closed-form constrained paths) is distinctive. However, the unresolved Eq. (16) discrepancy and overclaiming pull it below the cleanest anchors like Underdamped Diffusion Bridges (6.80) and BoPITO (7.00). Within the [5.5, 6.5] range, the paper is closest to Fisher-Rao Curves (6.40) and NETS (6.25) in overall quality when accounting for both contributions and flaws.

**Final score: 6.0**. This reflects the genuine theoretical + empirical contribution, discounted for the unresolved Eq. (16) issue and overclaiming. The paper is clearly above reject-level work (3.0–4.0) and has stronger experimental validation than many accepted papers in this area, but the mathematical inconsistency prevents a higher score without author clarification.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>